ASK REDCHAT ANYTHING ABOUT OLEMA PHARMACEUTICALS, INC.
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA)
Listen to this Section
$9.88
-0.0050
(
-0.05% )
3.7K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Market Data
|
| Open |
$9.88 |
| Previous Close |
$9.88 |
| Volume |
3.7K |
| Market Cap |
$862.99M |
| Day Range |
$9.86 - $10.29 |
| 52 Week Range |
$3.90 - $36.26 |
| Shares Outstanding |
87.35M |
| Change % |
-0.05% |
| Net Change |
▼ -0.0050 |
| Insider Ownership |
-0.48% |
| Exchange |
NASDAQ |
| Sector | Miscellaneous |
| Industry | None |
| IPO Year | 2020 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,014,565.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-05 |
Sale |
-1870499.00 |
Paradigm Biocapital Advisors LP |
| 2024-07-31 |
Sale |
-4066.00 |
Harmon Cyrus |
| 2024-07-12 |
Sale |
-5000.00 |
Harmon Cyrus |
| 2024-07-02 |
Sale |
-20000.00 |
Harmon Cyrus |
| 2024-06-18 |
Sale |
-23000.00 |
BVF PARTNERS L P/IL |
| 2024-06-18 |
Sale |
-23000.00 |
Harmon Cyrus |
| 2024-06-18 |
Sale |
-23000.00 |
Horning Sandra |
| 2024-06-18 |
Sale |
-23000.00 |
RAPPAPORT ANDREW |
| 2024-06-18 |
Sale |
-23000.00 |
Graham G. Walmsley |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
14 |
Nov 10, 2025 |
| 10-q |
Quarterly Reports |
68 |
Nov 10, 2025 |
| 8-k |
8K-related |
52 |
Oct 20, 2025 |
| 4 |
Insider transactions |
1 |
Sep 18, 2025 |
| 8-k |
8K-related |
12 |
Sep 02, 2025 |
| 10-q |
Quarterly Reports |
70 |
Aug 11, 2025 |
| 8-k |
8K-related |
53 |
Aug 11, 2025 |
| 4 |
Insider transactions |
1 |
Jun 13, 2025 |
| 4 |
Insider transactions |
1 |
Jun 13, 2025 |
| 4 |
Insider transactions |
1 |
Jun 13, 2025 |